Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial

OBJECTIVE: Type 1 diabetes (T1D) is characterised by islet autoimmunity and beta cell destruction. A gut microbiota–immunological interplay is involved in the pathophysiology of T1D. We studied microbiota-mediated effects on disease progression in patients with type 1 diabetes using faecal microbiot...

Descripción completa

Detalles Bibliográficos
Autores principales: de Groot, Pieter, Nikolic, Tanja, Pellegrini, Silvia, Sordi, Valeria, Imangaliyev, Sultan, Rampanelli, Elena, Hanssen, Nordin, Attaye, Ilias, Bakker, Guido, Duinkerken, Gaby, Joosten, Antoinette, Prodan, Andrei, Levin, Evgeni, Levels, Han, Potter van Loon, Bartjan, van Bon, Arianne, Brouwer, Catherina, van Dam, Sytze, Simsek, Suat, van Raalte, Daniel, Stam, Frank, Gerdes, Victor, Hoogma, Roel, Diekman, Martin, Gerding, Martin, Rustemeijer, Cees, de Bakker, Bernadette, Hoekstra, Joost, Zwinderman, Aeilko, Bergman, Jacques, Holleman, Frits, Piemonti, Lorenzo, De Vos, Willem, Roep, Bart, Nieuwdorp, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Gut Microbiota
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788262/
https://www.ncbi.nlm.nih.gov/pubmed/33106354
http://dx.doi.org/10.1136/gutjnl-2020-322630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788262/
https://www.ncbi.nlm.nih.gov/pubmed/33106354
http://dx.doi.org/10.1136/gutjnl-2020-322630

Ejemplares similares